Viewing Study NCT00302757


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-01-04 @ 8:53 PM
Study NCT ID: NCT00302757
Status: COMPLETED
Last Update Posted: 2014-05-29
First Post: 2006-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma
Sponsor:
Organization: